Approximately 2,000 new patients are diagnosed with mesothelioma every year. With over 300 consultations per year, the International Mesothelioma Program at Brigham and Women's Hospital / Harvard Medical School is the largest program of its kind in the world. Our ultimate mission is to offer state-of-the-art treatment to patients with malignant pleural mesothelioma.
Patients Talk with Dr. David Sugarbaker, Founder of the International Mesothelioma Program
The International Mesothelioma Program (IMP) encompasses a clinical program, a research program and a support program. Our clinical focus is on developing treatment strategies that can significantly extend the life of our patients. Our research focus involves a collaboration of basic, translational, and clinical research scientists whose aim is to understand the causative factors in the development of the disease and to translate these findings into improved therapy. Our dedicated mesothelioma support team provides counseling, emotional and spiritual support as well as practical help with housing and financial needs.
"When hope is in the equation, anything is possible"
That's what BWH Chief of Thoracic Surgery David Sugarbaker, MD, told the family of mesothelioma patient Charlie Chew, who was featured in an episode of "Boston Med." (Summer 2010)
Hear what Dr. Sugarbaker has to say about Mr. Chew and the team members who played a crucial role in saving his life.
View the trailer for the episode.
Send Feedback to: International Mesothelioma Program
This page was last modified on 9/6/2012